Interestingly, when comparing controls with AD patients, five proteins; CLM-6, Contactin-5 (CNTN5), serine/threonine-protein kinase receptor R3 (SKR3), urokinase-type plasminogen activator (uPA), and TGF-α were expressed differently depending on sample material. This evidence concerns the gene CD300C and Alzheimer disease.